23308088|t|Fibroblast growth factor receptor-mediated activation of AKT-beta-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cells.
23308088|a|UNLABELLED: Fibroblast Growth Factor (FGF)-10 promotes the proliferation and survival of murine hepatoblasts during early stages of hepatogenesis through a Wnt-beta-catenin dependent pathway. To determine the mechanism by which this occurs, we expanded primary culture of hepatoblasts enriched for progenitor markers CD133 and CD49f from embryonic day (E) 12.5 fetal liver and an established tumor initiating stem cell line from Mat1a(-/-) livers in media conditioned with recombinant (r) FGF10 or rFGF7. FGF Receptor (R) activation resulted in the downstream activation of MAPK, PI3K-AKT, and beta-catenin pathways, as well as cellular proliferation. Additionally, increased levels of nuclear beta-catenin phosphorylated at Serine-552 in cultured primary hepatoblasts, Mat1a(-/-) cells, and also in ex vivo embryonic liver explants indicate AKT-dependent activation of beta-catenin downstream of FGFR activation; conversely, the addition of AKT inhibitor Ly294002 completely abrogated beta-catenin activation. FGFR activation-induced cell proliferation and survival were also inhibited by the compound ICG-001, a small molecule inhibitor of beta-catenin-CREB Binding Protein (CBP) in hepatoblasts, further indicating a CBP-dependent regulatory mechanism of beta-catenin activity. CONCLUSION: FGF signaling regulates the proliferation and survival of embryonic and transformed progenitor cells in part through AKT-mediated activation of beta-catenin and downstream interaction with the transcriptional co-activator CBP.
23308088	57	60	AKT	Gene	11651
23308088	61	73	beta-catenin	Gene	12387
23308088	74	77	CBP	Gene	12914
23308088	126	132	murine	Species	10090
23308088	150	163	hepatic tumor	Disease	MESH:D009369
23308088	199	232	Fibroblast Growth Factor (FGF)-10	Gene	14165
23308088	276	282	murine	Species	10090
23308088	347	359	beta-catenin	Gene	12387
23308088	504	509	CD133	Gene	19126
23308088	514	519	CD49f	Gene	16403
23308088	579	584	tumor	Disease	MESH:D009369
23308088	616	621	Mat1a	Gene	11720
23308088	676	681	FGF10	Gene	14165
23308088	772	775	AKT	Gene	11651
23308088	781	793	beta-catenin	Gene	12387
23308088	881	893	beta-catenin	Gene	12387
23308088	957	962	Mat1a	Gene	11720
23308088	1029	1032	AKT	Gene	11651
23308088	1057	1069	beta-catenin	Gene	12387
23308088	1129	1132	AKT	Gene	11651
23308088	1143	1151	Ly294002	Chemical	MESH:C085911
23308088	1173	1185	beta-catenin	Gene	12387
23308088	1290	1297	ICG-001	Chemical	MESH:C492448
23308088	1329	1341	beta-catenin	Gene	12387
23308088	1342	1362	CREB Binding Protein	Gene	12914
23308088	1364	1367	CBP	Gene	12914
23308088	1407	1410	CBP	Gene	12914
23308088	1445	1457	beta-catenin	Gene	12387
23308088	1597	1600	AKT	Gene	11651
23308088	1624	1636	beta-catenin	Gene	12387
23308088	1702	1705	CBP	Gene	12914
23308088	Association	12387	12914
23308088	Association	MESH:D009369	11651
23308088	Association	MESH:D009369	11720
23308088	Association	11651	12914
23308088	Association	MESH:D009369	12387
23308088	Negative_Correlation	MESH:C085911	11651
23308088	Negative_Correlation	MESH:C085911	12387
23308088	Negative_Correlation	MESH:C492448	12914
23308088	Association	11651	12387
23308088	Negative_Correlation	MESH:C492448	12387
23308088	Association	MESH:D009369	12914
23308088	Association	12387	14165

